Price Targets
📊 Target Price Analysis:
- Baseline (3-Month Target): $295 - $305. This blends: a re-rating from the news (applying a ~5% uplift to the fundamentals report’s $299 target), a move towards the mid-point of its recent trading range ($271-$330), and a recovery to test the 60-day MA (~$297) as resistance-turns-support.
- Optimistic (6-Month Target): $315 - $325. Assumes successful early market reception of “NEXT” initiatives, leading to upward revisions in same-store sales estimates and multiple expansion. This targets the upper end of the fundamental range and the early 2026 resistance zone.
- Conservative (1-Month Target / Near-Term Resistance): $285 - $290. This is the initial relief rally target, covering the gap towards the 20-day SMA and the psychological $290 level. It represents the first leg of the recovery.
Primary Risk: The execution risk of the “NEXT” strategy is real. If early rollouts are poorly received or costs spiral, the positive sentiment will reverse quickly. However, at this price, with the stock oversold and the strategy just announced, I believe the reward for being early on a potential turnaround outweighs the risk of further downside from already-pessimistic levels.